UTHR FY 2009 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

UTHRUnited Therapeutics Corporation

$24B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$370M+31.4% YoY

Gross Profit

$325M87.7% margin

Operating Income

$26M7.0% margin

Net Income

$19M5.3% margin

EPS (Diluted)

$0.35

Cash Flow

Operating Cash Flow

$98M

Free Cash Flow

$2M

Stock-Based Comp.

$101M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$399M

Stockholders' Equity

$653M

Cash & Equivalents

$100M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$370M	$281M	+31.4%
Gross Profit	$325M	$251M	+29.1%
Operating Income	$26M	-$82M	+131.7%
Net Income	$19M	-$43M	+145.5%